Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live

Donald Trump & Pfizer

15 shared events · Importance 5 · Last updated Aug 11, 2026

Importance
5
Shared Events
15
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
49
Regulatory
Donald Trump: Donald Trump initiated the United States — Medicaid pilot program and other initiatives aimed at reducing U.S. prescription drug prices.
Pfizer: Pfizer previously signed a deal with the administration regarding drug pricing and co-developed Xtandi with Astellas Pharma.
Apr 20, 2026 · 6 articles
35
Business
Donald Trump: Held off on strikes against Iran, easing oil prices. Pushed for lower rates.
Pfizer: Reported upbeat quarterly results, leading to a stock gain.
Jul 14, 2026 · 280 articles
35
Domestic
Donald Trump: Beneficiary of the controversy as it undermines his predecessor's administration.
Pfizer: Mentioned as vaccine manufacturer; no direct impact from diary release.
Jul 29, 2026 · 13 articles
30
Business
Donald Trump: Donald Trump's administration has prioritized domestic investment, and AstraZeneca has already committed $50 billion to US manufacturing. The merger would likely need approval from his antitrust authorities.
Pfizer: Pfizer is referenced as a historical comparator, having attempted a hostile takeover of AstraZeneca in 2014. The current talks evoke memories of that failed bid.
Aug 02, 2026 · 60 articles
30
Regulatory
Donald Trump: As President, Trump's administration has overseen vaccine policy changes and FDA leadership, influencing the regulatory climate.
Pfizer: Pfizer, a rival in mRNA vaccines, may face competitive pressure as Moderna expands its mRNA platform into flu.
Aug 05, 2026 · 105 articles
30
Domestic
Donald Trump: Signed an executive order on childhood vaccines; his administration is not directly involved in the Fauci texts but is part of the political backdrop.
Pfizer: One of the vaccine manufacturers; the controversy may slightly affect public perception, but no direct impact.
Aug 06, 2026 · 17 articles
21
Regulatory
Donald Trump: President Trump has promoted AI advancement as crucial to economic and national security, but is not directly involved in eminent domain disputes.
Pfizer: Pfizer facility was the intended beneficiary of the Kelo seizure, but the company later left New London.
Jul 16, 2026 · 6 articles
20
Accidents
Donald Trump: Donald Trump's administration has been criticized for withdrawing from the World Health Organization and restricting United States — Centers for Disease Control and Prevention scientists, contributing to the agency's diminished capacity.
Pfizer: Pfizer is mentioned in false conspiracy theories linking its vaccine to the Hantavirus outbreak, which health officials are working to counter.
May 07, 2026 · 368 articles
20
Tech
Donald Trump: As President, Trump's administration has pushed back on mRNA technology, but the trial results may influence policy and public perception.
Pfizer: Pfizer, which partnered with BioNTech on COVID vaccines, may benefit indirectly from the validation of mRNA technology.
Aug 19, 2026 · 102 articles
10
Regulatory
Donald Trump: Donald Trump, US President, was a subject of discussion in the 'Washington Group' chat, which was reportedly set up to exchange messages when he did 'something wild and potentially damaging'.
Pfizer: Pfizer was mentioned in the context of a previous transparency dispute involving Ursula von der Leyen's text messages with its CEO, Albert Bourla, regarding COVID-19 vaccine contracts.
Jun 24, 2026 · 6 articles
0
Regulatory
Pfizer: Pfizer previously agreed to lower the cost of prescription drugs for United States — Medicaid following an executive order, setting a precedent for the current deal with Eli Lilly and Company and Novo Nordisk.
Nov 06, 2025 · 6 articles
0
Regulatory
Pfizer: Pfizer had previously struck a deal with the administration to rein in prices and expects United States — Medicaid discounts to result in price and margin compression next year.
Dec 19, 2025 · 7 articles
0
Regulatory
Apr 02, 2026 · 23 articles
0
Domestic
Mar 16, 2026 · 22 articles
0
Domestic
May 18, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Donald Trump and Pfizer interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.